Recent studies of ibogaine at Stanford University and elsewhere suggest that it might prove effective in treating post-traumatic stress disorder, …
Rick Perry: Texas invests $100 million in ibogaine research, the compound’s potential for treating addiction and PTSD, and the urgent need for medical integration
Key Takeaways
- Texas is making a significant investment in ibogaine research with a $100 million commitment.
- Ibogaine has the potential to address physiological substance dependence and enhance personal agency.
- The compound shows promise in treating various addictions, including opioids and alcohol.
- Ibogaine is being explored for its therapeutic benefits in serious medical conditions like multiple sclerosis and Parkinson’s.
- There is an urgent need to integrate promising therapies like ibogaine into the US medical system.
- Ibogaine is recognized for its ...
DOUGLAS BILL ADVANCING IBOGAINE RESEARCH FRAMEWORK CLEARS SENATE COMMITTEE — Kentucky Senate GOP
FRANKFORT, Ky. (March 12, 2026) — Legislation sponsored by Sen. Donald Douglas, R-Nicholasville, aimed at creating a research framework for ibogaine-based treatments has passed the Senate committee process unanimously and now heads to the Senate floor for consideration.
Senate Bill 77 establishes a structured framework allowing Kentucky to explore the scientific and clinical potential of ibogaine in the treatment of opioid use disorder, co-occurring substance use disorders, ...
Universal Ibogaine Inc (IBOGF) Earnings, Actual EPS, EPS Estimates & Results – Stocktwits
Checkout Universal Ibogaine Inc (IBOGF) earnings results, EPS expectations and actual EPS values for both quarterly and annual periods.
Texas To Fund Its Own Ibogaine Clinical Trials After Industry Balks
Texas hates when people get high, but the state is on its way toward legalizing ibogaine, a potent, potentially fatal hallucinogen.
Illustration by Sarah Schumacher
Texas might be heading into the psychedelic business alone after failing to find a drug company to partner with on clinical trials.
State lawmakers approved $50 million in funding for clinical trials with ibogaine, a psychoactive drug derived ...